| Dr Michael S Summerfield, DO | |
|
800 Garfield Ave, Parkersburg, WV 26101-5340 | |
| (304) 422-1666 | |
| (904) 346-0113 |
| Full Name | Dr Michael S Summerfield |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 24 Years |
| Location | 800 Garfield Ave, Parkersburg, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578509311 | NPI | - | NPPES |
| 2495821 | Medicaid | OH | |
| I09214 | Other | WV | WV WCOMP |
| 2217 | Other | OH | OH WCOMP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | I09214 (West Virginia) | Primary |
| 207P00000X | Emergency Medicine | 34-00-7861-S (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Magruder Hospital | Port clinton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allen Emergency Physicians Llc | 9739554379 | 10 |
News Archive
Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.
Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that it has added an additional investor, PPD, Inc., to its Series C financing. The final addition of PPD brings the total funding for this round to $25 million.
Johnson & Johnson Innovation LLC today announced developers at CertaDose, Inc. have won its latest QuickFire Challenge: Advancing the Safe Use of Healthcare Products. The challenge called for potentially game-changing, early stage, innovative ideas to help advance the safe use of healthcare products.
› Verified 6 days ago
| Entity Name | Physicians Link Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235172925 PECOS PAC ID: 8527969492 Enrollment ID: O20040405000838 |
News Archive
Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.
Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that it has added an additional investor, PPD, Inc., to its Series C financing. The final addition of PPD brings the total funding for this round to $25 million.
Johnson & Johnson Innovation LLC today announced developers at CertaDose, Inc. have won its latest QuickFire Challenge: Advancing the Safe Use of Healthcare Products. The challenge called for potentially game-changing, early stage, innovative ideas to help advance the safe use of healthcare products.
› Verified 6 days ago
| Entity Name | Emergency Professional Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093762353 PECOS PAC ID: 7214832435 Enrollment ID: O20040511000864 |
News Archive
Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.
Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that it has added an additional investor, PPD, Inc., to its Series C financing. The final addition of PPD brings the total funding for this round to $25 million.
Johnson & Johnson Innovation LLC today announced developers at CertaDose, Inc. have won its latest QuickFire Challenge: Advancing the Safe Use of Healthcare Products. The challenge called for potentially game-changing, early stage, innovative ideas to help advance the safe use of healthcare products.
› Verified 6 days ago
| Entity Name | Emergency Medical Services Of Lorain, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043455785 PECOS PAC ID: 1153486022 Enrollment ID: O20090210000668 |
News Archive
Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.
Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that it has added an additional investor, PPD, Inc., to its Series C financing. The final addition of PPD brings the total funding for this round to $25 million.
Johnson & Johnson Innovation LLC today announced developers at CertaDose, Inc. have won its latest QuickFire Challenge: Advancing the Safe Use of Healthcare Products. The challenge called for potentially game-changing, early stage, innovative ideas to help advance the safe use of healthcare products.
› Verified 6 days ago
| Entity Name | Magis Emergency Medicine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801287511 PECOS PAC ID: 2769700392 Enrollment ID: O20150410002555 |
News Archive
Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.
Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that it has added an additional investor, PPD, Inc., to its Series C financing. The final addition of PPD brings the total funding for this round to $25 million.
Johnson & Johnson Innovation LLC today announced developers at CertaDose, Inc. have won its latest QuickFire Challenge: Advancing the Safe Use of Healthcare Products. The challenge called for potentially game-changing, early stage, innovative ideas to help advance the safe use of healthcare products.
› Verified 6 days ago
| Entity Name | Pomerene Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770957185 PECOS PAC ID: 5496856270 Enrollment ID: O20160208000863 |
News Archive
Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.
Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that it has added an additional investor, PPD, Inc., to its Series C financing. The final addition of PPD brings the total funding for this round to $25 million.
Johnson & Johnson Innovation LLC today announced developers at CertaDose, Inc. have won its latest QuickFire Challenge: Advancing the Safe Use of Healthcare Products. The challenge called for potentially game-changing, early stage, innovative ideas to help advance the safe use of healthcare products.
› Verified 6 days ago
| Entity Name | Allen Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841902814 PECOS PAC ID: 9739554379 Enrollment ID: O20230412001703 |
News Archive
Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.
Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that it has added an additional investor, PPD, Inc., to its Series C financing. The final addition of PPD brings the total funding for this round to $25 million.
Johnson & Johnson Innovation LLC today announced developers at CertaDose, Inc. have won its latest QuickFire Challenge: Advancing the Safe Use of Healthcare Products. The challenge called for potentially game-changing, early stage, innovative ideas to help advance the safe use of healthcare products.
› Verified 6 days ago
| Entity Name | Lorain Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427760487 PECOS PAC ID: 0244605608 Enrollment ID: O20230417002556 |
News Archive
Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.
Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that it has added an additional investor, PPD, Inc., to its Series C financing. The final addition of PPD brings the total funding for this round to $25 million.
Johnson & Johnson Innovation LLC today announced developers at CertaDose, Inc. have won its latest QuickFire Challenge: Advancing the Safe Use of Healthcare Products. The challenge called for potentially game-changing, early stage, innovative ideas to help advance the safe use of healthcare products.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael S Summerfield, DO Po Box 759008, Baltimore, MD 21275-0001 Ph: (304) 422-1666 | Dr Michael S Summerfield, DO 800 Garfield Ave, Parkersburg, WV 26101-5340 Ph: (304) 422-1666 |
News Archive
Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.
Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that it has added an additional investor, PPD, Inc., to its Series C financing. The final addition of PPD brings the total funding for this round to $25 million.
Johnson & Johnson Innovation LLC today announced developers at CertaDose, Inc. have won its latest QuickFire Challenge: Advancing the Safe Use of Healthcare Products. The challenge called for potentially game-changing, early stage, innovative ideas to help advance the safe use of healthcare products.
› Verified 6 days ago
Dr. Michael M Dickerson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Garfield Ave, Healing Center At Ccmh, Parkersburg, WV 26101 Phone: 304-424-2228 Fax: 304-420-7128 | |
Wayne B Cayton Jr., MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Garfield Ave, Parkersburg, WV 26101 Phone: 304-424-2111 Fax: 904-346-0113 | |
Ethan Westbrook, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Garfield Ave Rm G102, Parkersburg, WV 26101 Phone: 304-424-4575 Fax: 304-424-4577 | |
Dr. Andrew Christian Retzinger, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Garfield Ave, Parkersburg, WV 26101 Phone: 304-424-2111 | |
Dr. Joseph Lantz, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Garfield Ave, Parkersburg, WV 26101 Phone: 304-488-9093 | |
Keith Waggoner, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1824 Murdoch Ave, Parkersburg, WV 26101 Phone: 304-424-4111 Fax: 330-656-5901 | |
Brian K Richardson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Garfield Ave, Parkersburg, WV 26101 Phone: 304-424-2111 Fax: 904-346-0113 |